The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The potential of organometallic complexes in medicinal chemistry
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
The therapeutic potential of carbon monoxide
Motterlini, R., & Otterbein, L. E. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3228 · Cited by 1,638
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Self-citationCisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes
Morris, R. E., Aird, R. E., del Socorro Murdoch, P., Chen, H., Cummings, J., Hughes, N. D., Parsons, S., Parkin, A., Boyd, G., Jodrell, D. I., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010051m · Cited by 787
The Medicinal Applications of Imidazolium Carbene−Metal Complexes
Hindi, K. M., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2009) · Chemical Reviews · doi:10.1021/cr800500u · Cited by 776
Using coordination chemistry to design new medicines
Ronconi, L., & Sadler, P. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.11.017 · Cited by 608
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Melaiye, A., Sun, Z., Hindi, K., Milsted, A., Ely, D., Reneker, D. H., Tessier, C. A., & Youngs, W. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja040226s · Cited by 557
Allardyce, C. S., Dyson, P. J., Ellis, D. J., & Heath, S. L. (2001) · Chemical Communications · doi:10.1039/b104021a · Cited by 495
Targeting proteins with metal complexes
Meggers, E. (2009) · Chemical Communications · doi:10.1039/b813568a · Cited by 450
A categorization of metal anticancer compounds based on their mode of action
Gianferrara, T., Bratsos, I., & Alessio, E. (2009) · Dalton Transactions · doi:10.1039/b905798f · Cited by 336
Catalytic organometallic anticancer complexes
Dougan, S. J., Habtemariam, A., McHale, S. E., Parsons, S., & Sadler, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800076105 · Cited by 303
Exploring biologically relevant chemical space with metal complexes
Meggers, E. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.013 · Cited by 274
Targeted and multifunctional arene ruthenium chemotherapeutics
Smith, G. S., & Therrien, B. (2011) · Dalton Transactions · doi:10.1039/c1dt11007a · Cited by 262
Vessières, A., Top, S., Pigeon, P., Hillard, E., Boubeker, L., Spera, D., & Jaouen, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050251o · Cited by 206
Activation Mechanisms for Organometallic Anticancer Complexes
Pizarro, A. M., Habtemariam, A., & Sadler, P. J. (2010) · Topics in Organometallic Chemistry · doi:10.1007/978-3-642-13185-1_2 · Cited by 199
New Principles in Medicinal Organometallic Chemistry
Schatzschneider, U., & Metzler‐Nolte, N. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504604 · Cited by 194
Self-citationMann, B. E., & Motterlini, R. (2007) · Chemical Communications · doi:10.1039/b704873d · Cited by 172
Wang, F., Xu, J., Habtemariam, A., Bella, J., & Sadler, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053387k · Cited by 169
Zobi, F., Degonda, A., SCHAUB, M. C., & Bogdanova, A. Y. (2010) · Inorganic Chemistry · doi:10.1021/ic100458j · Cited by 140
Ferrocene Functionalized Endocrine Modulators as Anticancer Agents
Hillard, E. A., Vessières, A., & Jaouen, G. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_4 · Cited by 132
Youngs, W. J., Knapp, A. R., Wagers, P. O., & Tessier, C. A. (2011) · Dalton Transactions · doi:10.1039/c1dt11100k · Cited by 128
Carbon Monoxide: An Essential Signalling Molecule
Mann, B. E. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_10 · Cited by 124
17 e − rhenium dicarbonyl CO-releasing molecules on a cobalamin scaffold for biological application
Zobi, F., Blacque, O., Jacobs, R. A., SCHAUB, M. C., & Bogdanova, A. Y. (2011) · Dalton Transactions · doi:10.1039/c1dt10649j · Cited by 102
Similar Biological Activities of Two Isostructural Ruthenium and Osmium Complexes
Maksimoska, J., Williams, D. S., Atilla‐Gokcumen, G. E., Smalley, K. S. M., Carroll, P. J., Webster, R. D., Filippakopoulos, P., Knapp, S., Herlyn, M., & Meggers, E. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800294 · Cited by 89
Bioorganometallic Chemistry and Malaria
Biot, C., & Dive, D. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_7 · Cited by 83
Schlotter, K., Boeckler, F. M., Hübner, H., & Gmeiner, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050170s · Cited by 72
Wenzel, M., Patra, M., Albrecht, D., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00078-11 · Cited by 67
Medicinal Organometallic Chemistry
Jaouen, G., & Dyson, P. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045047-4/00173-4 · Cited by 62
Ruthenium and Other Non‐Platinum Anticancer Compounds
Bratsos, I., Gianferrara, T., Alessio, E., Hartinger, C. G., Jakupec, M. A., & Keppler, B. K. (2011) · Wiley eBooks · doi:10.1002/9783527633104.ch5 · Cited by 54
Organometallics as Structural Scaffolds for Enzyme Inhibitor Design
Mulcahy, S. P., & Meggers, E. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_6 · Cited by 36
Metal Compounds as Enzyme Inhibitors
Gasser, G., & Metzler‐Nolte, N. (2011) · doi:10.1002/9783527633104.ch12 · Cited by 25
Self-citation
Cited by
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
The medicinal chemistry of ferrocene and its derivatives
Patra, M., & Gasser, G. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0066 · Cited by 609
Self-citationMetal complexes as a promising source for new antibiotics
Frei, A., Zuegg, J., Elliott, A. G., Baker, M., Braese, S., Brown, C., Chen, F., G. Dowson, C., Dujardin, G., Jung, N., et al. (2020) · Chemical Science · doi:10.1039/c9sc06460e · Cited by 543
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Lee, S. Y., Kim, C. Y., & Nam, T.-G. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s275007 · Cited by 400
Metadata
- Authors
- Gasser, G., & Metzler-Nolte, N.
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 16
- Issue
- 1-2
- Pages
- 84-91
- ISSN
- 1367-5931 (ISSN-L)
- OpenAlex
- W1963719070
- Cited by
- 516
- References
- 34
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.